Anticoagulation and thromboembolic risk management in pharmacological and electrical cardioversion of atrial fibrillation: State of the evidence and knowledge gaps

Trends in Cardiovascular Medicine · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles